Acceptance of isoniazid preventive treatment by close contacts of tuberculosis cases: A 692-subject Italian study

International Journal of Tuberculosis and Lung Disease

Volumn 2, Issue 3, 1998, Pages 208-212

  Codecasa, L R ^a,b   Besozzi, G ^a  

^a Lombardy Reg Ref Ctr for TB   (Italy)

^b Istituto Villa Marelli   (Italy)

Author keywords

Acceptance; Immigrants; Isoniazid; Italy; Tuberculosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; ISONIAZID;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DEVELOPING COUNTRY; FOLLOW UP; HEADACHE; HEPATITIS; HUMAN; IMMIGRANT; INFANT; ITALY; MAJOR CLINICAL STUDY; MUSCLE CRAMP; NAUSEA; PATIENT COMPLIANCE; PRIORITY JOURNAL; RASH; RETROSPECTIVE STUDY; THORAX RADIOGRAPHY; TUBERCULIN TEST; TUBERCULOSIS; VISUAL DISORDER; VOMITING;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; EMIGRATION AND IMMIGRATION; HUMANS; INFANT; ISONIAZID; ITALY; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; TUBERCULOSIS, PULMONARY;

EID: 0031914742     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Rieder H L, Cauthen G M, Kelly G D, Bloch A B, Snider D E Jr. Tuberculosis in the United States. JAMA 1989; 262: 385-389.
2. Raviglione M C, Sudre P, Rieder H L, Spinaci S, Kochi A. Secular trends of Tuberculosis in Western Europe. Bull World Health Organ 1993; 71: 297-306.
3. Rieder H L. Epidemiology of tuberculosis in Europe. Eur Respir J 1995; 8 (suppl 20): 620-632.
4. Codecasa A, Deco M P, Di Proietto M C, Codecasa L R. Possibili modificazioni dell'epidemiologia della tubercolosi nella città di Milano. Medicina Toracica 1991; 1: 47-53.
5. Mantellini P V. Eradicazione della tubercolosi in Italia. JAMA 1990; 2: 745-746.
6. Gruppo di Studio AIPO 'Tubercolosi'. Protocollo per il Controllo della Tubercolosi in Italia. Rass Pat App Resp 1995 (suppl): 1-86.
7. Centers for Disease Control. The use of preventive therapy for tuberculous infection in the United States. MMWR 1990; 39: 9-12.
8. Centers for Disease Control. Tuberculosis prevention in drug treatment centers and correctional facilities. MMWR 1993; 42: 210-213.
9. Camins B C, Bock N, Watkins D L, Blumberg H M. Acceptance of isoniazid preventive therapy by health care workers after skin test conversion. JAMA 1996; 275: 1013-1015.
10. Mansilla C A, De Palmero K E, Palmero D J. Comparison of the Mantoux intradermal reaction produced with two different biological products. Rev Arg de Tuberculosis, Enfermedades Pulmonares y Salud Publica 1984; 29-36.
11. American Thoracic Society. Medical Section of the American Lung Association. Control of tuberculosis in the United States. Am Rev Respir Dis 1992; 146: 1623-1633.
12. Johnson H, Lee B, Doherty E, Kelly E, McDonnell T. Tuberculin sensitivity and the BCG scar in tuberculosis contacts. Tubercle Lung Dis 1995; 76: 122-125.
13. Kilburn O J, Beam R E, David H L, Sanchez E, Corpe R F, Dunn W. Reagent-impregnated paper strip for detection of metabolic products of isoniazid in urine. Am Rev Respir Dis 1972; 106: 923-924.
14. Thompson N J. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up of the IUAT trial. Bull World Health Organ 1982; 60: 555-564.
15. Cinti C, Lavecchia M A, Canessa P A, Capecchi V. Esperienza di chemioprofilassi antitubercolare negli scolari di Bologna. Lotta Contro la TBC e Malattie Polmonari Soc 1993; 63: 134-138.
16. Codecasa L R, Besozzi G, Bulgheroni P V, Cinguino D, Sarassi A, Mantellini P V. Compliance to isoniazid chemoprophylaxis for TB. In: Am J Respir Crit Care Med 1995; 151: A515.
17. International Union Against Tuberculosis Committee on Prophylaxis. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. Bull World Health Organ 1982; 60: 555-564.
18. Kopanoff D E, Snider D E, Caras G J. Isoniazid related hepatitis. A US Public Health Service cooperative surveillance study. Am Rev Respir Dis 1978; 117: 991-1001.